It appears you have not yet Signed Up with our community. To Sign Up for free, please click here....



Cancer: Prostate Message Board
Post New Thread   Closed Thread
LinkBack Thread Tools
Old 02-13-2009, 03:28 PM   #1
Senior Veteran
(male)
 
Join Date: Nov 2007
Location: Annandale, VA, USA
Posts: 1,730
Blog Entries: 3
IADT3since2000 HB UserIADT3since2000 HB UserIADT3since2000 HB UserIADT3since2000 HB UserIADT3since2000 HB UserIADT3since2000 HB UserIADT3since2000 HB UserIADT3since2000 HB UserIADT3since2000 HB UserIADT3since2000 HB UserIADT3since2000 HB User
Smile Degarelix - new drug approved by FDA: magnificent achievement

There is a new kid on the hormonal therapy street, and his accomplishments to date are impressive!

The drug is degarelix, with the trade name yet to be determined, and the FDA approved this drug, developed by Ferring Pharmaceuticals, on December 31, 2008. Apparently it will be available very soon, once the trade name and label plus doctor and patient flier details are worked out.

I learned about its approval from the Us Too "Hot Sheet" for February 2009 that is given out at our support group meetings, and I've done some further checking on [url]www.pubmed.gov[/url] and elsewhere.

It supresses testosterone more rapidly than the drugs now available , such as Lupron, Zoladex, Viadur, Trelstar LA and Eligard. All of the latter are in the drug class known as "LHRH agonists," meaning that they stimulate the normal receptor on the pituitary gland, a circumstance that then fools the body into thinking that it has produced adequate testosterone so that it shuts down almost all of further production. That cuts off a key fuel needed by the prostate cancer cells. In contrast, degarelix is an "LHRH antagonist" drug, meaning that it blocks the receptor for LHRH so that the body cannot signal that it needs more testosterone. Degarelix is the only LHRH antagonist now approved by the FDA, though at least two others are apparently available in other countries.

How good is it? The randomized, open label (meaning not blinded) Phase III trial was overseen by two leading experts, Dr. Laurence Klotz (Toronto, Sunnybrook) and Dr. Fritz Schroeder (Schroder with umlaut), both well known for their work with active surveillance, among other accomlishments. Key results in head-to-head comparision with Lupron showed that "At Day 3 of treatment, 96% of degarelix patients achieved a castrate testosterone level compared with zero percent receiving leuprolide [Lupron]. By Day 14, 99% of degarelix patients achieved castrate levels of testosterone , compared with 18% receiving leuprolide...." The trial also demonstrated that no flare occurred with degarelix ; that's good, because flare is typical with drugs in the Lupron class, and wise practice is to use an antiandrogen drug to prevent it, thereby avoiding a risk that a temporary surge in testosterone will cause irreversible trouble .

Generally, it was well tolerated, though injection site reactions were much more common (40%) than for Lupron (< 1.0%). However, less than 1% of patients discontinued degarelix, and severe injection site reactions occurred in 2% or fewer patients receiving the drug.

As you might expect, side effects are similar to those of the LHRH agonist class of drugs such as Lupron and Zoladex.

At this point, I'm highly impressed, but there is one piece of key data I would like to see: how well it does against a lower threshold for assuming adequate suppression of testosterone. Many researchers, including the researchers in this trial, feel that lowering testosterone to 50 ng/dL (same as .5 ng/mL) is adequate, but the leaders I follow, who are experts in hormonal blockade and who have practices dedicated to just prostate cancer, want testosterone to be below 20. If they do not see that, then they alter tactics. The abstracts of the studies gave only the percentages of patients achieving the looser level of 50 ng/dL. I'm hoping that the complete papers will provide the added detail, or alternately that the researchers will publish the added detail later.

I also am curious whether this drug will enable patients to dispense with the two other elements of triple blockade that round out my intermittent triple blockade therapy: the andiandrogen drug (like Casodex or flutamide), and the 5-alpha reductase class of drug (finasteride (formerly Proscar) or Avodart). Those questions are not clear from what I see at this point. However, from the graphic diagram on page 134 of "A Primer on Prostate Cancer - The Empowered Patient's Guide," it appears that degarelix would also cancel the signal that triggers indirect production of testosterone by the adrenal gland, even if it does not block the androgen receptor, as Casodex (etc.) does.

But I'm getting analytical here - it's a habit, since I think my life may depend on it.

Taking a larger view, it is clear that development of degarelix is a magnificent accomplishment!

Jim

Last edited by IADT3since2000; 02-13-2009 at 03:41 PM. Reason: Spelling, grammar, added phrase.

 
Sponsors Lightbulb
   
Old 02-18-2009, 08:23 AM   #2
Senior Member
(male)
 
Join Date: Oct 2008
Location: Welland, Ontario, Canada
Posts: 114
flyfisher37 HB Userflyfisher37 HB Userflyfisher37 HB User
Re: Degarelix - new drug approved by FDA: magnificent achievement

Hi Jim,

Good news indeed! Since Dr. Klotz is from Toronto, that could possibly mean that the drug might even be available in Canada, when all the paperwork is done. That would be good for anyone here that is going to need hormone therapy, possibly myself included.

Hopefully, the radiation will eliminate my cancer, but I know that my chances are far from 100%. I will be done in a few more weeks and then I will have to wait a period of time for a psa test ( I'm not sure how long at this point ) to find out if the radiation has done it's job. If not, then I'll be looking at hormone therapy.

Take care. Lionel

 
Old 02-18-2009, 02:38 PM   #3
Veteran
(male)
 
Join Date: Aug 2006
Location: NJ,USA
Posts: 362
shs50 HB User
Re: Degarelix - new drug approved by FDA: magnificent achievement

Great news for those needing hormone therapy. Sounds like the 2nd generation LHRH drugs is here.

 
Closed Thread

Similar Threads
Thread Thread Starter Board Replies Last Post
The FDA approved artificial discs 10/2004 for lumbar spine, Cervical to follow snicklefritz Back Problems 17 01-25-2012 03:12 PM
FDA's newly proposed drug registry brianpain33 Pain Management 12 06-30-2009 07:53 PM
Savella drug due out in March 2009-we'll see. DeBeachSiren Fibromyalgia 8 03-13-2009 08:24 AM
so many meds so many side effects katiemarie87 Bipolar Disorder 14 02-20-2008 09:25 AM
New FDA Approval of Drug Phoenix Fibromyalgia 3 06-26-2007 11:14 AM




Thread Tools

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is Off
HTML code is Off
Trackbacks are Off
Pingbacks are Off
Refbacks are Off




Join Our Newsletter

Stay healthy through tips curated by our health experts.

Whoops,

There was a problem adding your email Try again

Thank You

Your email has been added




Top 10 Drugs Discussed on this Board.
(Go to DrugTalk.com for complete list)
Casodex
Cialis
Cipro
Flomax
Levaquin
  Levitra
Morphine
Proscar
Tylenol
Viagra




TOP THANKED CONTRIBUTORS



Tall Allen (174), IADT3since2000 (148), Baptista (97), Gleason9 (28), harpman (27), Johnt1 (22), honda50 (9), tumbleweed (6), flyfisher37 (6), GUAMJOHN (5)

Site Wide Totals

teteri66 (1139), MSJayhawk (943), Apollo123 (860), janewhite1 (823), Titchou (774), Gabriel (743), ladybud (667), sammy64 (666), midwest1 (655), BlueSkies14 (610)



All times are GMT -7. The time now is 10:35 AM.



Site owned and operated by HealthBoards.com™
Copyright and Terms of Use © 1998-2014 HealthBoards.comô All rights reserved.
Do not copy or redistribute in any form!